Copyright
©The Author(s) 2022.
World J Gastrointest Pathophysiol. Jan 22, 2022; 13(1): 1-14
Published online Jan 22, 2022. doi: 10.4291/wjgp.v13.i1.1
Published online Jan 22, 2022. doi: 10.4291/wjgp.v13.i1.1
Function | Pathways and genetic regulators |
Proliferation | Wnt pathway: MYC, FGF19, APC, AXINMAPK/ERK signaling pathway: mTOR, ERK 1/2 |
Cell growth and angiogenesis | RTK/RAS/PI(3)K pathway: PIK3CA, VEGF, EGF, MET, KRAS, PTEN, AKT1/2, FGFR1, NF1, TSC1/2, TGF-β pathway: SMAD2/3, SMAD4 |
Apoptosis | TP53 signaling pathway: MDM4, MDM2, CDKN2A, RPS6KA3 |
Cell immortality | Telomerase production: TERT |
Cell cycle progression | RB1, CCND1, CDK4, CCNE1 |
Cell differentiation | HNF1A |
Autophagy | RAS/RAF/MEK/ERK pathway, PI3K-AKT (AKT kinase)-mTOR pathway, and Wnt/β-catenin signaling pathway: Becilin-1, ATG3, ATG5, ATG7 |
Inflammatory response | IL-6 stimulation: STAT3, HNF1, IL6ST, GNAS |
Chromatin modifiers | BAP1, ARID1A/B, IDH1/2, SMACA4, KMT2D |
- Citation: El-Nakeep S. Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises). World J Gastrointest Pathophysiol 2022; 13(1): 1-14
- URL: https://www.wjgnet.com/2150-5330/full/v13/i1/1.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v13.i1.1